Egg Oral Immunotherapy

NCT01489553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2013-10-22

No results posted yet for this study

Summary

For patients with Immunoglobulin E (IgE)-mediated food allergy, the current management includes identification of the causative food and avoidance. Egg allergy is among the most common causes of IgE-mediated food allergy in children, affecting approximately 1.6% of children (its prevalence is higher in children with atopic dermatitis or other food allergies). Given the prevalence of egg and the difficulty to avoid it in the diet, we aim to investigate the safety and efficacy of baked egg oral immunotherapy.

Conditions

  • Egg Hypersensitivity

Sponsors & Collaborators

Principal Investigators

  • Jonathan M. Spergel, MD, PhD · Children's Hospital of Philadelphia

  • Rushani W. Saltzman, MD · Children's Hospital of Philadelphia

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-09-30
Completion
2013-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01489553 on ClinicalTrials.gov